Remarkably, in both ADC and SCC, incorporating the expression levels of KIAA1522 successfully stratified one group of lung adenocarcinoma patients with the most favorable outcomes, who express lower level of KIAA1522 and underwent platinum-based chemotherapy (Fig. 1e). Here, NHSL3 is linked to lung adenocarcinoma.